Presentations & Publications
// Aug 18, 2026 | eBook
From Discovery to GMP: Building Scalable Cell Therapy Manufacturing
// Aug 17, 2026 | Publication
Cytotherapy
Understanding FDA’s reasons for nonapproval: A systematic review of complete response letters in cell and gene therapy
// July 6-9, 2026 | Poster
FASEB Genome Engineering: Research and Applications
Discovery and validation of novel, high-efficiency large serine recombinases for targeted gene insertion
// Jun 16, 2026 | Webinar
Outsourced Pharma Capabilities Update
Scaling Cell Therapy Manufacturing: From Tech Transfer to High-Volume Readiness
// June 10-12, 2026 | Poster
CRISPR 2026
Discovery and validation of novel, high-efficiency large serine recombinases for targeted gene insertion
// Jun 10, 2026 | Presentation
CASSS Cell and Gene Therapy Products Symposium 2026
CMC considerations for CRISPR and next-gen technologies, including ElevateBio’s LETI-101 as a case study
// Jun 01, 2026 | Presentation
CGT Talk 2026
Beyond Mountains of Papers and DataLakes: The Promise of LLMs in augmenting Manufacturing
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Sequencing-based analytics offer potential for rapid sterility and adventitious agent testing
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Engineering hepatocyte-targeted LNPs for RNA and DNA delivery to primary human T cells
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Harnessing a diverse collection of CRISPR-associated RNA-guided nucleases and novel reverse transcriptases for precise gene editing
// May 14, 2026 | Presentation
American Society of Gene and Cell Therapy (ASGCT)
Next‑generation enzymes for targeted gene insertion
// May 14, 2026 | Presentation
American Society of Gene and Cell Therapy (ASGCT)
